• Søren Rud Kristensen, Rachel Meacock, Alex J Turner, Ruth Boaden, Ruth McDonald, Martin Roland, and Matthew Sutton.
• From the Manchester Centre for Health Economics, Institute of Population Health (S.R.K., R. Meacock, A.J.T., M.S.), and Manchester Business School (R.B.), University of Manchester, Manchester, the Warwick Business School, University of Warwick, Warwick (R. McDonald), and the Cambridge Centre for Health Services Research, University of Cambridge, Cambridge (M.R.) - all in the United Kingdom.
• N. Engl. J. Med. 2014 Aug 7; 371 (6): 540-8.

BackgroundA pay-for-performance program based on the Hospital Quality Incentive Demonstration was introduced in all hospitals in the northwest region of England in 2008 and was associated with a short-term (18-month) reduction in mortality. We analyzed the long-term effects of this program, called Advancing Quality.MethodsWe analyzed 30-day in-hospital mortality among 1,825,518 hospital admissions for eight conditions, three of which were covered by the financial-incentive program. The hospitals studied included the 24 hospitals in the northwest region that were participating in the program and 137 elsewhere in England that were not participating. We used difference-in-differences regression analysis to compare risk-adjusted mortality for an 18-month period before the program was introduced with subsequent mortality in the short term (the first 18 months of the program) and the longer term (the next 24 months).ResultsThroughout the short-term and the long-term periods, the performance of hospitals in the incentive program continued to improve and mortality for the three conditions covered by the program continued to fall. However, the reduction in mortality among patients with these conditions was greater in the control hospitals (those not participating in the program) than in the hospitals that were participating in the program (by 0.7 percentage points; 95% confidence interval [CI], 0.3 to 1.2). By the end of the 42-month follow-up period, the reduced mortality in the participating hospitals was no longer significant (-0.1 percentage points; 95% CI, -0.6 to 0.3). From the short term to the longer term, the mortality for conditions not covered by the program fell more in the participating hospitals than in the control hospitals (by 1.2 percentage points; 95% CI, 0.4 to 2.0), raising the possibility of a positive spillover effect on care for conditions not covered by the program.ConclusionsShort-term relative reductions in mortality for conditions linked to financial incentives in hospitals participating in a pay-for-performance program in England were not maintained.

19 keywords...

hide…